PET assessment of myocardial perfusion reserve inversely correlates with intravascular ultrasound findings in angiographically normal cardiac transplant recipients

Journal of Nuclear Medicine

Volumn 51, Issue 6, 2010, Pages 906-912

  Wu, Yen Wen ^a,b   Chen, Ying Hsien ^b   Wang, Shoei Shen ^a,b   Jui, Hsiang Yiang ^a,b   Yen, Ruoh Fang ^a,b   Tzen, Kai Yuan ^a,b   Chen, Ming Fong ^a,b   Lee, Chii Ming ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cardiac allograft vasculopathy; Myocardial perfusion quantification; Positron emission tomography; Transplantation

Indexed keywords

ADENOSINE; AMMONIA; NITROGEN 13; DIAGNOSTIC AGENT;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTERY OCCLUSION; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIAC ALLOGRAFT VASCULOPATHY; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE MARKER; FEMALE; GRAFT RECIPIENT; HEART EJECTION FRACTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HEART TRANSPLANTATION; HUMAN; HYPEREMIA; INTRAVASCULAR ULTRASOUND; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; CHEMISTRY; CORONARY BLOOD VESSEL; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; HEART; MIDDLE AGED; PATHOPHYSIOLOGY; SCINTISCANNING; TIME; VASCULAR DISEASE;

ADULT; AGED; AMMONIA; CORONARY ANGIOGRAPHY; CORONARY VESSELS; FEMALE; HEART; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; TIME FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL; VASCULAR DISEASES; YOUNG ADULT;

EID: 77953920164     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.073833     Document Type: Article

References (52)

1. Schmauss D, Weis M. Cardiac allograft vasculopathy: recent developments. Circulation. 2008;117:2131-2141.
2. Kass M, Allan R, Haddad H. Diagnosis of graft coronary artery disease. Curr Opin Cardiol. 2007;22:139-145.
3. Johnson DE, Aldermann EL, Scroeder JS, et al. Transplant coronary artery disease: histopathologic correlations with angiographic morphology. J Am Coll Cardiol. 1991;17:449-457.
4. St. Goar FG, Pinto FJ, Aldermann EL, et al. Intracoronary ultrasound in cardial transplant recipients: in vivo evidence of angiographically silent intimal thickening. Circulation. 1992;85:979-987.
5. Spes CH, Klauss V, Rieber J, et al. Functional and morphological findings in heart transplant recipients with a normal coronary angiogram: an analysis by dobutamine stress echocardiography, intracoronary Doppler and intravascular ultrasound. J Heart Lung Transplant. 1999;18:391-398.
6. Stork S, Behr TM, Birk M, et al. Assessment of cardiac allograft vasculopathy late after heart transplantation: when is coronary angiography necessary? J Heart Lung Transplant. 2006;25:1103-1175.
7. Lee CM, Wu YW, Chou NK, et al. Intravascular ultrasound evidence of angiographically silent allograft vasculopathy inversely correlates with circulating level of hepatocyte growth factor. J Heart Lung Transplant. 2006;25:1456-1461.
8. Lee CM, Wu YW, Jui HY, et al. Intravascular ultrasound correlates with coronary flow reserve and predicts the survival in angiographically silent cardiac transplant recipients. Cardiology. 2008;109:93-98.
9. Hendel RC, Berman DS, Di Carli MF, et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/ SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine: endorsed by the American College of Emergency Physicians. Circulation. 2009;119:e561-e587.
10. Shaw LJ, Narula J. Risk assessment and predictive value of coronary artery disease testing. J Nucl Med. 2009;50:1296-1306.
11. Di Carli MF, Hachamovitch R. New technology for noninvasive evaluation of coronary artery disease. Circulation. 2007;115:1464-1480.
12. Bengel FM, Higuchi T, Javadi MS, Lautamäki R. Cardiac positron emission tomography. J Am Coll Cardiol. 2009;54:1-15.
13. Yen RF, Ho YL, Chou NK, Hsu RB, Huang PJ. Inhomogeneity of myocardial perfusion in heart transplant recipients: evaluation with dobutamine thallium-201 SPECT. Nucl Med Commun. 2001;22:1015-1019.
14. Wu YW, Yen RF, Lee CM, et al. Usefulness of progressive inhomogeneity of myocardial perfusion and chronotropic incompetence in detecting cardiac allograft vasculopathy: evaluation with dobutamine thallium-201 myocardial SPECT. Cardiology. 2005;104:156-161.
15. Wu YW, Yen RF, Lee CM, et al. Diagnostic and prognostic value of dobutamine thallium-201 single-photon emission computed tomography after heart transplantation. J Heart Lung Transplant. 2005;24:544-550.
16. Puskás C, Kosch M, Kerber S, et al. Progressive heterogeneity of myocardial perfusion in heart transplant recipients detected by thallium-201 myocardial SPECT. J Nucl Med. 1997;38:760-765.
17. Muzik O, Beanlands RS, Hutchins GD, et al. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med. 1993;34:83-91.
18. Uren NG, Melin JA, De Bruyne B, et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med. 1994;330:1782-1788.
19. Kaufmann PA, Camici PG. Myocardial blood flow by PET: technical aspects and clinical applications. J Nucl Med. 2005;46:75-88.
20. Graf S, Khorsand A, Gwechenberger M, et al. Typical chest pain and normal coronary angiogram: cardiac risk factor analysis versus PET for detection of microvascular disease. J Nucl Med. 2007;48:175-181.
21. Sdringola S, Loghin C, Boccalandro F, Gould KL. Mechanisms of progression and regression of coronary artery disease by PET related to treatment intensity and clinical events at long-term follow-up. J Nucl Med. 2006;47:59-67.
22. Tio RA, Dabeshlim A, Siebelink H-MJ, et al. Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease. J Nucl Med. 2009;50:214-219.
23. 13N-ammonia myocardial perfusion positron emission tomography: added value of coronary flow reserve. J Am Coll Cardiol. 2009;54:150-156.
24. Neglia D, Michelassi C, Trivieri MG, et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation. 2002;105:186-193.
25. Cecchi F, Olivotto I, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med. 2003;349:1027-1035.
26. Allen-Auerbach M, Schöder H, Johnson J, et al. Relationship between coronary function by positron emission tomography and temporal changes in morphology by intravascular ultrasound (IVUS) in transplant recipients. J Heart Lung Transplant. 1999;18:211-219.
27. Preumont N, Berkenboom G, Vachiery J, et al. Early alterations of myocardial blood flow reserve in heart transplant recipients with angiographically normal coronary arteries. J Heart Lung Transplant. 2000;19:538-545.
28. Klauss V, Ackermann K, Henneke KH, et al. Epicardial intimal thickening in transplant coronary artery disease and resistance vessel response to adenosine: a combined intravascular ultrasound and Doppler study. Circulation. 1997;96(suppl):II-159-II-164.
29. Kofoed KF, Czernin J, Johnson J, et al. Effects of cardiac allograft vasculopathy on myocardial blood flow, vasodilatory capacity, and coronary vasomotion. Circulation. 1997;95:600-606.
30. Pethig K, Heublein B, Meliss RR, Haverich A. Volumetric remodeling of the proximal left coronary artery: early versus late after heart transplantation. J Am Coll Cardiol. 1999;34:197-203.
31. Fearon WF, Nakamura M, Lee DP, et al. Simultaneous assessment of fractional and coronary flow reserves in cardiac transplant recipients: Physiologic Investigation for Transplant Arteriopathy (PITA study). Circulation. 2003;108:1605-1610.
32. Fearon WF, Hirohata A, Nakamura M, et al. Discordant changes in epicardial and microvascular coronary physiology after cardiac transplantation: Physiologic Investigation for Transplant Arteriopathy II (PITA II) study. J Heart Lung Transplant. 2006;25:765-771.
33. Rodrigues AC, Frimm Cde C, Bacal F, et al. Coronary flow reserve impairment predicts cardiac events in heart transplant patients with preserved left ventricular function. Int J Cardiol. 2005;103:201-206.
34. Schubert S, Abdul-Khaliq H, Wellnhofer E, et al. Coronary flow reserve measurement detects transplant coronary artery disease in pediatric heart transplant patients. J Heart Lung Transplant. 2008;27:514-521.
35. Jorg-Ciopor M, Namdar M, Turina J, et al. Regional myocardial ischemia in hypertrophic cardiomyopathy: impact of myectomy. J Thorac Cardiovasc Surg. 2004;128:163-169.
36. Machac J, Bacharach SL, Bateman TM, et al. Positron emission tomography myocardial perfusion and glucose metabolism imaging. J Nucl Cardiol. 2006;13:e121-e151.
37. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation. 2002;105:539-542.
38. Zellweger MJ, Hachamovitach R, Kang X, et al. The threshold, incidence, and predictors of prognostically high-risk silent ischemia in asymptomatic patients without prior diagnosis ofcoronary artery disease. J Nucl Cardiol. 2009;16:193-200.
39. 13N-ammonia and PET. J Nucl Cardiol. 1996;3:494-507.
40. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med. 2007;356:830-840.
41. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant. 1990;9:587-593.
42. Schelbert HR, Phelps ME, Huang SC, et al. N-13 ammonia as an indicator of myocardial blood flow. Circulation. 1981;63:1259-1272.
43. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert H, Kuhl DE. Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol. 1990;15:1032-1042.
44. Gould KL, Martucci JP, Goldberg DI, et al. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. Circulation. 1994;89:1530-1538.
45. Sdringola S, Nakagawa K, Nakagawa Y, et al. Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease. J Am Coll Cardiol. 2003;41:263-272.
46. Wielepp P, Baller D, Gleichmann U, Pulawski E, Horstkotte D, Burchert W. Beneficial effects of atorvastatin on myocardial regions with initially low vasodilatory capacity at various stages of coronary artery disease. Eur J Nucl Med Mol Imaging. 2005;32:1371-1377.
47. Higuchi T, Abletshauser C, Nekolla SG, Schwaiger M, Bengel FM. Effect of the angiotensin receptor blocker Valsartan on coronary microvascular flow reserve in moderately hypertensive patients with stable coronary artery disease. Microcirculation. 2007;14:805-812.
48. Sdringola S, Gould KL, Zamarka LG, McLain R, Garner J. A 6 month randomized, double blind, placebo controlled, multi-center trial of high dose atorvastatin on myocardial perfusion abnormalities by positron emission tomography in coronary artery disease. Am Heart J. 2008;155:245-253.
49. 13N-ammonia myocardial perfusion imaging with a PET/CT scanner: impact on clinical decision making and cost-effectiveness. Eur J Nucl Med Mol Imaging. 2008;35:889-895.
50. Hirohata A, Nakamura M, Waseda K, et al. Changes in coronary anatomy and physiology after heart transplantation. Am J Cardiol. 2007;99:1603-1607. (Pubitemid 46770649)
51. Fearon WF, Potena L, Hirohata A, et al. Changes in coronary arterial dimensions early after cardiac transplantation. Transplantation. 2007;83:700-705.
52. Sakurai R, Yamasaki M, Nakamura M, et al. Determinants of lumen loss between years 1 and 2 after cardiac transplantation. Transplantation. 2007;84:1097-1102.